Sizmek to Present at 28th Annual Roth Conference
Feb 25, 2016 21:10 pm UTC| Business
AUSTIN, Texas, Feb. 25, 2016 -- Sizmek Inc. (NASDAQ:SZMK), a global open ad management company that delivers multiscreen, multichannel campaigns, today announced that Ken Saunders, CFO will present at the 28th Annual...
Jones Soda Announces Fourth Quarter and Year-End 2015 Earnings Conference Call
Feb 25, 2016 21:10 pm UTC| Business
SEATTLE, Feb. 25, 2016 -- Jones Soda Co. (OTCQB:JSDA), a leader in the premium soda category and known for its unique branding and innovative marketing, today announced that it will host a conference call to discuss...
TESARO Announces Fourth-Quarter 2015 Operating Results
Feb 25, 2016 21:06 pm UTC| Business
U.S. commercial launch of VARUBI® (oral rolapitant) well underwayNiraparib Phase 3 NOVA results expected in Q2 2016 are positioned to be the first data from a randomized, prospective Phase 3 trial of a PARP inhibitorNew...
MOCON Reports Fourth Quarter and Annual 2015 Results
Feb 25, 2016 21:05 pm UTC| Business
2015 Highlights: Overall revenue grew 3 percent on a Constant Currency basisDouble digit annual growth in core businesses (Permeation and Package Testing Segments) on a Constant Currency basisFully diluted earnings per...
Lifetime Brands to Report Fourth Quarter 2015 Financial Results on Friday, March 11, 2016
Feb 25, 2016 21:05 pm UTC| Business
GARDEN CITY, N.Y., Feb. 25, 2016 -- Lifetime Brands, Inc. (NASDAQ:LCUT), a leading global provider of kitchenware, tableware and other products used in the home, will release its fourth quarter 2015 financial results at...
Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update
Feb 25, 2016 21:05 pm UTC| Business
NOVATO, Calif., Feb. 25, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...
Peregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of Bavituximab
Feb 25, 2016 21:05 pm UTC| Business
TUSTIN, Calif., Feb. 25, 2016 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today...